StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
175140.KQ$3070.00-2.69%
Fair $3070.00+0.0%

175140.KQ

HUMAN TECHNOLOGY Co., Ltd

Technology / Communication EquipmentKOSDAQ

$3070.00

-85.00 (-2.69%)

Fairly Valued+0.0%Fair Value $3070.00Fund rank 31/100 · Data gapFallback financials|
SA 23/D
F-Score: 4/9
Low Profitability

FCF base 3Y

n/d

n/d CAGR · yield n/d

FCF base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 33% · confianza 23%

FCF escenarios

weak_data · normalized FCF $-9.5B · quality 67.0/100

Data gap 31/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 31/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

23/100

D

Piotroski

4/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

16/100

SEC 0%

Latest source: unknownPeriods: 4Warnings: 1unknown: 4
No SEC-backed annual rows; valuation uses fallback financial data. Insufficient audited annual history (<3 SEC-backed years); composite fair value and forward targets are disabled until manually verified. ROE is -44.7%, below the 5% threshold
Thesis & Journal · 175140.KQLocal privado en este navegador · HUMAN TECHNOLOGY Co., Ltd
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$76.1B

P/E

N/A

•

EV/EBITDA

N/A

•

ROE

-44.7%

↓

Gross Margin

16.8%

↓

Debt/Equity

0.20

↓
52-Week Range$3070
$2890$6870

TradingView lightweight chart

175140.KQ price, volumen y niveles de valoración

Último $3,070Periodo -84.7%
Fair value: $3,070

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2022–2025 · 3 años de histórico normalizado

Revenue CAGR

+16.0%

FCF CAGR

—

FCF margin

-17.0%

FCF / Net income

0.52x

Latest source

Provider fallback

Margin decomposition

Último año: revenue $55.49B · net income $-18.30B · FCF $-9.45B

2022-FY → 2025-FY

Gross margin

16.8%+7.7% pts

Operating margin

-20.0%+2.3% pts

Net margin

-33.0%-4.1% pts

FCF margin

-17.0%+34.5% pts
MetricTTM
2025
2024
2023
2022
Income Statement
Revenue$55.49B$55.49B$42.68B$38.50B$35.54B
Net Income$-18.30B$-18.30B$-15.98B$-14.17B$-10.25B
EBITDA$-14.88B$-14.88B$-13.39B$-13.60B$-8.14B
EPS-756.00-756.00-791.00-921.00-1245.00
Gross Margin16.8%16.8%18.4%1.5%9.1%
Operating Margin-20.0%-20.0%-11.9%-20.8%-22.3%
Net Margin-33.0%-33.0%-37.4%-36.8%-28.8%
Balance Sheet
Debt/Equity0.200.200.220.070.24
Current Ratio2.612.61———
Cash Flow
Free Cash Flow$-9.45B$-9.45B$-2.54B$-19.94B$-18.30B
Returns
ROE-44.7%-44.7%-37.3%-33.1%-24.8%
Valuation
P/B1.821.822.271.321.10
Growth & Yield
Revenue Growth30.0%30.0%10.9%8.3%—
EPS Growth4.4%4.4%14.1%26.0%—

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%
Reverse DCF requires positive EPS; loss-making or zero-EPS companies cannot produce a clean EPS hurdle.

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · 1Y approxreconcilia total -35.6%

Total return

-35.6%

Start / end P/E

n/dx → n/dx

EPS bridge

-791.00 → -756.00

Residual

-35.6%

EPS growthn/d
Multiple reratingn/d
Dividend+0.0%
Residual / FX / buybacks / cross-term-35.6%

EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.